Home › Heart Attack › Mississippi
Heart Attack clinical trials in Mississippi
3 studies for Heart Attack are looking for participants at sites in Mississippi.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Nephrology Associates, PC, Columbus
- - Nephrology and Hypertension Associates Ltd, Tupelo
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Belzoni Clinical Research, Belzoni
- Stern Cardiovascular Foundation Inc, Southaven
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Jackson Heart Clinic, Jackson
- Cardiology Associates Research LLC, Tupelo
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.